Arlington Trust CO LLC Neogenomics Inc Transaction History
Arlington Trust CO LLC
- $468 Million
- Q1 2025
A detailed history of Arlington Trust CO LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Arlington Trust CO LLC holds 108 shares of NEO stock, worth $775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108
Previous 108
-0.0%
Holding current value
$775
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
288Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$141 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$102 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$48.2 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$43.4 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$41.2 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $903M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...